Arcutis Biotherapeutics Inc. (ARQT)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
21. 35
+0.56
+2.69%
$
2.65B Market Cap
- P/E Ratio
- Div Yield
976,932 Volume
-3.88 Eps
$ 20.79
Previous Close 
Want to track ARQT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.02 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ARQT Earnings Reports FAQ
What is the earnings per share (EPS) for ARQT?
The current EPS is -3.88.
What is the company's earnings growth rate?
Arcutis Biotherapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Arcutis Biotherapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Arcutis Biotherapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ARQT at this time, as Arcutis Biotherapeutics Inc has no recent EPS data to calculate it.
